Market Signals Diverge as AI Infrastructure Expansion Meets Defensive HedgingGlobal Report·18 hours agoVOR+11.51%NB+11.40%
Top Biotech Gainers: WGRX Rebrands, PVLA Nears FDA Milestone, ASBP On Track For NDA Filingrttnews·Jul 21 at 10:25 PMASBP+19.79%DYAI+0.94%
RA Capital Healthcare Fund disposes of 213 Vor Biopharma shares worth $4,206.75PUBT·Jul 21 at 03:55 PMVOR+11.51%
Vor Biopharma (NASDAQ:VOR) Stock Price Up 12% - What's Next?Market Beat·Jul 21 at 01:20 PMVOR+11.51%BAC+1.08%
Vor Biopharma Inc. (NASDAQ:VOR) Given Average Recommendation of "Moderate Buy" by AnalystsMarket Beat·Jul 15 at 01:44 AMVOR+11.51%GS-C-0.21%
Vor Biopharma director David Zaccardelli files initial beneficial ownership statementPUBT·Jul 9 at 03:01 PMVOR+11.51%
Vor Bio grants inducement awards to new hires, including options for 71,200 shares at $18.39PUBT·Jul 2 at 04:30 PMVOR+11.51%
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | VOR Stock NewsStockTitan·Jul 2 at 08:30 AMVOR+11.51%
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)Unusual Whales·Jun 12 at 01:10 PMVOR+11.51%
Telitacicept Receives NMPA Approval for the Treatment of Sjögren’s Disease in China | VOR Stock NewsStockTitan·Jun 7 at 11:31 PM09995+4.03%688331+2.59%
